Cargando…
Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease
Effective treatment options for advanced colorectal cancer (CRC) are limited, survival rates are poor and this disease continues to be a leading cause of cancer-related deaths worldwide. Despite being a highly heterogeneous disease, a large subset of individuals with sporadic CRC typically harbor re...
Autores principales: | Belmont, Peter J., Budinska, Eva, Jiang, Ping, Sinnamon, Mark J., Coffee, Erin, Roper, Jatin, Xie, Tao, Rejto, Paul A., Derkits, Sahra, Sansom, Owen J., Delorenzi, Mauro, Tejpar, Sabine, Hung, Kenneth E., Martin, Eric S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036469/ https://www.ncbi.nlm.nih.gov/pubmed/24742783 http://dx.doi.org/10.1242/dmm.013904 |
Ejemplares similares
-
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
por: Popovici, Vlad, et al.
Publicado: (2013) -
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
por: Roper, Jatin, et al.
Publicado: (2011) -
p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epithelium
por: Cole, Alicia M, et al.
Publicado: (2010) -
A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
por: Xie, Tao, et al.
Publicado: (2012) -
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
por: Budinska, Eva, et al.
Publicado: (2013)